-
Megestat capsule, a rare drug, was "conditionally approved" by CDE
Time of Update: 2020-04-03
It was learned from the second Beijing rare diseases academic conference that megestat capsule, a rare disease drug, has obtained the qualification of "conditional approval" from the drug evaluation c
-
Chuanshegan flavone capsule, a new Chinese medicine of Fengchun pharmaceutical, has obtained the production approval and new drug certificate
Time of Update: 2020-04-03
Recently, Sichuan Fengchun Pharmaceutical Co., Ltd applied for chuanshegan flavone capsule, a new Chinese medicine, which has been approved for production and marketing after Sichuan Kangding Jinzhu P
-
Clinical application of two class 1 new drugs in Guangdong dongyangguang Pharmaceutical Co., Ltd
Time of Update: 2020-04-03
According to the website of the State Food and drug administration, Guangdong dongyangguang Pharmaceutical Co., Ltd applied for the clinical approval of two class 1 new drugs, respectively, laelotinib
-
New epilepsy drug dp-vpa jointly developed by Enhua pharmaceutical and d-pharm in Israel has entered the phase III clinical trial
Time of Update: 2020-04-03
Jiangsu Enhua Pharmaceutical Co., Ltd said in the morning of February 14 that the dp-vpa innovative drug jointly developed by Enhua pharmaceutical and Israeli d-pharm company is currently in the phase
-
Three specifications of irbesartan hydrochlorothiazide tablets of Huahai Pharmaceutical Co., Ltd. have been approved by FDA for listing
Time of Update: 2020-04-03
In the evening of May 12, Huahai pharmaceutical announced that the company's three specifications of irbesartan hydrochlorothiazide tablets were approved by FDA for listing Irbesartan hydrochlorothiaz
-
Minutes of overseas authorized conference call of Hengrui pharmaceutical PD-1
Time of Update: 2020-04-03
The company has signed an agreement with Incyte company, the main content of which is: within 30 days after receiving the receipt from Hengrui, Incyte company of the United States will pay the down pa
-
Vaccine independently developed in China has been pre certified by who for the first time
Time of Update: 2020-04-03
The reporter learned from the State Food and Drug Administration on September 9 that the World Health Organization announced in Geneva that China's independently developed "live attenuated encephalit
-
The bioequivalence test of bosentan tablet, an imitative drug for pulmonary disease treatment in Zhejiang Province, will be carried out soon
Time of Update: 2020-04-03
According to the information on the website of the State Food and Drug Administration (CFDA), the evaluation status of bosentan tablet, a heavy-duty generic drug for lung disease declared by Zhejiang
-
Joint research of Takeda pharmaceutical and Sumitomo pharmaceutical: lurasidone approved by EU
Time of Update: 2020-04-03
Recently, lurasidone, jointly developed by Takeda pharmaceutical and Sumitomo pharmaceutical, has been approved by the European Union for the treatment of adult patients with schizophrenia The drug wi
-
The patent of belinostat, the only drug for T-cell lymphoma treatment by Wanle pharmaceutical, was approved
Time of Update: 2020-04-03
The patent "a method to synthesize belinostat" applied by Wanle pharmaceutical, a subsidiary of Guoyao group united Pharmaceutical Co., Ltd., has been issued a patent certificate by the State Intellec
-
Fuan Pharmaceutical Co., Ltd. obtained the clinical approval for the treatment of hypertension with lekadipine hydrochloride
Time of Update: 2020-04-03
According to the information on CFDA website, Fuan Pharmaceutical (300194 SZ) has completed the examination and approval of lekadipine hydrochloride and its preparation for hypertension People from th
-
Breakthrough in research and development of genetic engineering vaccine for HFMD of Chinese Academy of Sciences
Time of Update: 2020-04-03
Liu Qingwei, Ph.D candidate of vaccine science and antiviral strategy research group of Shanghai Pasteur Institute of Chinese Academy of Sciences, developed a genetically engineered vaccine against Co
-
Flupentixol-t-melitracen tablet, a new antidepressant drug of HISCO, was first imitated in the field
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on May 21, Flupentixol tablets, a 6-class antidepressant drug of Hisilicon, entered the site for examination this month and ar
-
Apatinib, a class 1 heavy drug of Hengrui medicine, has held an expert review meeting last week
Time of Update: 2020-04-03
Apatinib, a heavyweight new drug of Hengrui pharmaceutical, held an expert review meeting last week According to people familiar with the matter, the result of the expert review meeting is approved pr
-
Shanghai Kaibao 8.5 million yuan to introduce "Huadan Anshen mixture" new drug technology and patent right
Time of Update: 2020-04-03
Shanghai Kaibao Pharmaceutical Co., Ltd announced in the evening of January 13, 2014 that the company recently used its own funds of 8.5 million yuan to purchase new drug technology and patent rights
-
Baiyunshan Pharmaceutical launched the first traditional Chinese medicine "Viagra" TieMa
Time of Update: 2020-04-03
According to the news from Baiyunshan Heji Huangpu traditional Chinese Medicine Co., Ltd., the first traditional Chinese medicine "Viagra" Baiyunshan TieMa developed and produced by the company was of
-
The triptolide anti arthritis project of Hong Kong Baptist University won the national "major new drug creation" special project in 2013
Time of Update: 2020-04-03
The research project of "Tripterygium wilfordii modified by aptamer against arthritis" jointly carried out by the Institute of bone and joint disease transformation medicine of Hong Kong Baptist Unive
-
Tenofovir dipivoxil fumarate (raw material + tablet), a Class 3 hepatitis B drug of Anke biology, will obtain clinical approval
Time of Update: 2020-04-03
Tenofovir fumarate dipivoxil tablet is the original research drug of Gilead company in the United States Its trade name is "viride" It is a new type of nucleoside oral antiviral drug, which is used to
-
Changshan Pharmaceutical Co., Ltd. is expected to obtain production approval before the Spring Festival
Time of Update: 2020-04-03
Changshan pharmaceutical industry has made progress in the approval process of heparin sodium According to the website of the State Food and Drug Administration (CFDA), the production status of six ch
-
A batch of new drugs for lung cancer and cerebrovascular disease break foreign monopoly or fill domestic gaps
Time of Update: 2020-04-03
Wang Chen, deputy director of the science and Education Department of the health and Family Planning Commission, said at today's conference that China has developed a number of high-quality and low-co
